Advancement in the 1L Treatment of Unresectable or Metastatic HCC: A Case-Based Review of the IMbrave150 Trial
Watch our previous webinar, which took place Tuesday, 11 May 2021 on the topic of Treatment and Management of HCC using the IMBrave 150 Regimen.
The HCC Branded Speaker program is a case-based branded speaker program designed to educate other HCPs about the treatment and management of HCC using the IMbrave150 regimen.
Case studies are used as a basis to address the following topics:
- Disease Overview and Staging
- IMbrave150 Clinical Trial
- Important Safety Information